Natera

About Natera

Natera is a global leader in cell-free DNA testing, dedicated to oncology, women's health, and organ health. The company aims to make personalized genetic testing and diagnostics part of the standard of care.

Natera develops and sells noninvasive cell-free DNA tests for oncology, women's health, organ health, and rare diseases. Their tests include Signatera for minimal residual disease, Prospera for transplant assessment, and Panorama for prenatal screening. They serve patients, clinicians, and biopharma partners. Revenue comes from test sales to healthcare providers and patients, as well as biopharma collaborations.